An audit evaluation of the effect of sodium glucose cotransporter inhibitors as an add-on to injectable therapy in Type 2 diabetes

被引：0
|
作者：
Krishnan, G. P. A. [1 ]
Shields, K. [1 ]
Nally, J. [1 ]
Boyle, J. G. [2 ]
机构：
[1] Glasgow Caledonian Univ, Glasgow, Lanark, Scotland
[2] Glasgow Royal Infirm, Glasgow, Lanark, Scotland
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P186
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [1] Effect of Add-On Therapy of Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase 4 Inhibitors on Adipokines in Type 2 Diabetes Mellitus
    Shaheer, Abid
    Kumar, Ashok
    Menon, Palat
    Jallo, Mahir
    Basha, Shaikh
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (06): : 355 - 362
  • [2] Comparison of Efficacy and Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors as Add-On Therapy in Patients With Type 2 Diabetes
    Hussain, Mazhar
    Elahi, Asim
    Iqbal, Javed
    Ghafoor, Muhammad
    Rehman, Habib
    Akhtar, Shoaib
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [3] Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
    Jeon, Ja Young
    Ha, Kyoung Hwa
    Kim, Dae Jung
    DIABETES & METABOLISM JOURNAL, 2021, 45 (04) : 505 - 514
  • [4] Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials
    Lunwen Rao
    Chenhong Ren
    Shan Luo
    Chenghu Huang
    Xuefeng Li
    Acta Diabetologica, 2021, 58 : 869 - 880
  • [5] Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
    Bae, Jaehyun
    Kim, Young-eun
    Lee, Minyoung
    Lee, Yong-ho
    Lee, Byung-Wan
    Cha, Bong-Soo
    Kang, Eun Seok
    YONSEI MEDICAL JOURNAL, 2022, 63 (06) : 539 - 544
  • [6] Sodium-glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials
    Rao, Lunwen
    Ren, Chenhong
    Luo, Shan
    Huang, Chenghu
    Li, Xuefeng
    ACTA DIABETOLOGICA, 2021, 58 (07) : 869 - 880
  • [7] Efficacy and safety of sodium-glucose cotransporter 2 inhibitors as add-on to metformin and sulfonylurea treatment for the management of type 2 diabetes: a meta-analysis
    Li, Jian
    Shao, Ying-hong
    Wang, Xiao-gang
    Gong, Yanping
    Li, Chunlin
    Lu, Yanhui
    ENDOCRINE JOURNAL, 2018, 65 (03) : 335 - 344
  • [8] Sodium-glucose cotransporter inhibitors as add-on therapy in addition to insulin for type 1 diabetes mellitus: A meta-analysis of randomized controlled trials
    Zou, Hailan
    Liu, Lili
    Guo, Jia
    Wang, Hongjuan
    Liu, Siyun
    Xing, Yixuan
    Deng, Chao
    Xiao, Yang
    Zhou, Zhiguang
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (04) : 546 - 556
  • [9] A Study on Safety and Efficacy of Sodium-glucose Cotransporter-2 Inhibitors as Adjuvant to Insulin Add-on Therapy in Uncontrolled Type 2 Diabetic Patients
    Mary, P. S. Alfeena
    Varghese, Giphy Susan
    Sunny, Glancy K.
    Prabakar, J. Harish
    Andhuvan, G.
    ASIAN JOURNAL OF PHARMACEUTICS, 2018, 12 (03) : S896 - S900
  • [10] Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes
    Henry, Robert R.
    Thakkar, Payal
    Tong, Cindy
    Polidori, David
    Alba, Maria
    DIABETES CARE, 2015, 38 (12) : 2258 - 2265
12345